Clinical significance of CD45 and CD200 expression in newly diagnosed multiple myeloma patients.
10.11817/j.issn.1672-7347.2025.240154
- Author:
Xinyi LONG
1
,
2
,
3
;
Jing LIU
1
;
Rong HU
4
;
Chen WANG
4
;
Yunfeng FU
5
Author Information
1. Department of Hematology, Third Xiangya Hospital, Central South University, Changsha
2. longxy0326@
3. com.
4. Department of Hematology, Shengjing Hospital of China Medical University, Shenyang
5. Department of Blood Transfusion, Third Xiangya Hospital, Central South University, Changsha 410013, China. fuyunfeng@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
CD200;
CD45;
flow cytometry;
multiple myeloma;
prognosis
- MeSH:
Humans;
Multiple Myeloma/metabolism*;
Male;
Female;
Middle Aged;
Antigens, CD/metabolism*;
Prognosis;
Leukocyte Common Antigens/metabolism*;
Aged;
Adult;
Immunophenotyping;
Nomograms;
Biomarkers, Tumor;
Clinical Relevance
- From:
Journal of Central South University(Medical Sciences)
2025;50(4):545-559
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Multiple myeloma (MM) is a hematologically malignant clonal plasma cell disease. This study aims to explore the association between immunophenotypes and prognosis in patients with MM, to determine whether the expression of CD45 and CD200 is related to the prognosis of newly diagnosed MM (NDMM) patients, and to evaluate the significance of the combined expression of CD45 and CD200 in NDMM.
METHODS:A total of 123 NDMM patients admitted to Shengjing Hospital of China Medical University from July 2015 to August 2019 were enrolled. Five key immunophenotypic markers (including CD38, CD138, CD45, CD56, and CD200) were screened through flow cytometry and identified using random forest analysis and univariate Cox regression analysis. Patients were divided into 3 groups: Group A, CD45 and CD200 double-positive; Group B, CD45 or CD200 single-positive; Group C, CD45 and CD200 double-negative. Kaplan-Meier curves were used to analyze overall survival (OS) and progression-free survival (PFS) across groups. Multivariate Cox regression was performed to evaluate prognostic factors, and a nomogram was constructed based on these results.
RESULTS:The OS and PFS of single-positive groups for CD38, CD138, CD45, CD56, and CD200 were all shorter than those of their respective single-negative groups (all P<0.05). Significant differences were observed in OS (P<0.001) and PFS (P=0.001) among Groups A, B, and C. Group A had shorter OS and PFS (all P=0.001) compared to the Group B+C (cases from Group B and Group C were combined). CD45 and CD200 double-positive was an independent prognostic factor for NDMM [hazard ratio (HR)=2.178, 95% confidence interval (CI) 1.048 to 4.529; P=0.037]. The nomogram and calibration curves constructed from multivariate Cox regression analysis demonstrated good concordance (concordance index=0.706; 95% CI 0.661 to 0.751).
CONCLUSIONS:NDMM patients with double-positive expression of CD45 and CD200 have significantly shorter OS and PFS. Compared with the use of either marker alone, the combined assessment of CD45 and CD200 may provide better prognostic stratification for MM patients.
